Skip to main content

Peer Review reports

From: The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer

Original Submission
17 Jul 2023 Submitted Original manuscript
21 Aug 2023 Author responded Author comments - Louis-Bastien Weiswald
Resubmission - Version 2
21 Aug 2023 Submitted Manuscript version 2
1 Sep 2023 Editorially accepted
19 Sep 2023 Article published 10.1186/s12885-023-11362-8

You can find further information about peer review here.

Back to article page